Enter Symbol:

Stock Detail

ENDO PHARMACEUTICALS HOLDINGS INC

Drug Manufacturers Other

ENDP @ Yahoo Finance | ENDP Option @ Yahoo Finance

Last Day's Data

Current Price High Value Change Percent Change Dividend Previous Close
$32.91 $33.71 $-0.61 -1.82% 0.00 $33.52
Opening Price Low Volume Market Cap Average Volume P/E
$33.25 $32.79 770,751 3.85B 1.37M 16.33

Pivot Table

R2 R1 Pivot S1 S2
34.06 33.49 33.14 32.57 32.22

stock chart

Stock Profile

Endo Pharmaceuticals Holdings, Inc. operates as a specialty pharmaceutical company in the United States. Through its wholly owned subsidiary, Endo Pharmaceuticals, Inc., it engages in the research, development, marketing, and sale of branded and generic pharmaceutical products primarily used to treat and manage pain. The company's branded products include Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. Lidoderm is a topical patch product containing lidocaine for the relief of the pain from post-herpetic neuralgia. Percocet and Percodan are used for the treatment of moderate-to-severe pain. Frova used for prevention of menstrually related migraine. DepoDur used for the treatment of pain following major surgery. Zydone tablets are also used for the relief of moderate-to-severe pain and contain hydrocodone/acetaminophen. The company's generic products comprise morphine sulfate, generic oxycodone hydrochloride, and acetaminophen product, which focus on pain management. Endo Pharmaceuticals also offers carbidopa/levodopa, the generic version of Sinemet for the treatment of the symptoms of idiopathic Parkinson's disease. In addition, the company is developing products for the acute, chronic, and neuropathic pain conditions, as well as in complementary therapeutic areas. It sells its products to pharmacy chains and wholesale drug distributors who supply to pharmacies, hospitals, governmental agencies, and physicians. The company has a strategic alliance with SkyePharma, Inc. Endo was incorporated in 1997 and is headquartered in Chadds Ford, Pennsylvania.